Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02490527 · ClinicalTrials.gov registry record · NA
Effects of Epicatechin on Statins for Mitochondrial Dysfunction and Impaired Exercise Capacity
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT02490527 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 19 participants.
The verdict
NCT02490527, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The purpose of this study is to gain insight into the side-effects of statin consumption, and assess the ability of epicatechin (a compound in dark chocolate) to counteract or reverse these changes. The investigators' prior research has shown that epicatechin can improve skeletal muscle structure and mitochondrial (which gives us energy) structure.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Pure epicatechin capsules (50mg)
- DRUG Simvastatin (40mg)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2015-06 |
| Est. Completion | 2021-07-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02490527
The ClinicalTrials.gov registry entry for NCT02490527 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02490527 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02490527 about?
NCT02490527 is a clinical study titled "Effects of Epicatechin on Statins for Mitochondrial Dysfunction and Impaired Exercise Capacity". The purpose of this study is to gain insight into the side-effects of statin consumption, and assess the ability of epicatechin (a compound in dark chocolate) to counteract or reverse these changes. The investigators' prior research has shown that epicatechin can improve skeletal muscle structure an...
What is the current status of trial NCT02490527?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2015-06. Estimated completion is 2021-07-28.
What interventions are being tested in trial NCT02490527?
The interventions under investigation include: Placebo (OTHER), Pure epicatechin capsules (50mg) (DIETARY_SUPPLEMENT), Simvastatin (40mg) (DRUG).
Who is sponsoring clinical trial NCT02490527?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.